Loading viewer...
earnings
Format: PDF earnings
Maybank's nine-month financial results for FY2026 showing 6% growth in net profit to RM1.58 billion with ROE of 10.1% and ROA of 1.06%. The bank demonstrated strong performance with NII growth of 4% from NIM expansion and NOI growth of 10%, while maintaining disciplined cost management with CTI at 44.3%.
Teva Pharmaceutical Q2 2021 Results Earnings
earningsearnings
38 Pages
Teva Pharmaceutical Industries
brochure
earnings
23 Pages
AECOM